A post-hoc analysis presented at the American College of Cariology’s Annual Scientific Session suggests that maintaining functional stability, measured by 6-minute walk distance, is associated with lower...
A meta-analysis of randomized controlled trials presented at the American College of Cardiology’s Annual Scientific Session suggests RNA therapeutics reduce mortality and cardiac failure risk in...
New guideline recommendations from the ACC/AHA and 9 partner organizations prioritize earlier treatment, refined atherosclerotic cardiovascular disease risk prediction, and broader use of lipid biomarkers...
In a post-hoc analysis of ATTR-ACT, investigators examined whether baseline National Amyloidosis Center (NAC) stage influences long-term mortality, cardiovascular outcomes, and health status in patients...
A new cost-effectiveness modeling study evaluates whether coronary artery calcium scoring can refine cardiovascular risk stratification and help identify obese patients most likely to derive clinical and...
The FDA has cleared a once-daily oral semaglutide treatment for adults with obesity or overweight and weight-related conditions, based on phase 3 OASIS 4 trial results demonstrating significant mean weight...
A new ACC/AHA clinical practice guideline on managing adults with congenital heart disease updates its 2018 recommendations by integrating evidence from 2017 to 2024 and emphasizing specialized...
A large systematic review and meta-analysis published in the Journal of the American Heart Association evaluated evidence from 155 studies worldwide, identifying strong associations between several viral...
A new multicenter randomized clinical trial published in JAMA evaluated whether consuming caffeinated coffee affects the recurrence of atrial fibrillation (AF) after cardioversion. The findings suggest that...
